Hirofumi Kashii, Shinya Kasai, Atsushi Sato, Yoko Hagino, Yasumasa Nishito, Toshiyuki Kobayashi, Okio Hino, Masashi Mizuguchi, Kazutaka Ikeda. Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex. 2022
Hiroko Sugiura, Tadayuki Shimada, Keiko Moriya-Ito, Jun-Ichi Goto, Hiroki Fujiwara, Rie Ishii, Hiroshi Shitara, Choji Taya, Satoshi Fujii, Toshiyuki Kobayashi, et al. A Farnesyltransferase Inhibitor Restores Cognitive Deficits in Tsc2+/- Mice through Inhibition of Rheb1. The Journal of Neuroscience. 2022. 42. 12. 2598-2612
Exploring downstream pathways of Erc/Msln as therapeutic targets of TSC
(International Tuberous Sclerosis Complex Research Conference 2018 2018)
Education (4)：
- 1992 Nagoya University
- 1992 Nagoya University Graduate School, Division of Natural Science
- 1987 Niigata University Faculty of Science
- 1987 Niigata University Faculty of Science
Professional career (1)：
Doctor(Science) (Nagoya University)
Work history (6)：
1996 - 2004 (財)癌研究会癌研究所実験病理部 研究員
1996 - 2004 Associate, Dept. of Exp. Pathol., Cancer
1993 - 1996 (財)癌研究会癌研究所実験病理部 嘱託研究員
1993 - 1996 Attending Associate, Dept. of Exp. Pathol.,
Institute, Japanese
Cancer Institute, Japanese
Show all
Awards (1)：
1999 - 癌学会奨励賞
Association Membership(s) (8)：
The Japanese Society Of Child Neurology
, The Japanese Society of Tuberous Sclerosis Complex
, THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER
, The Japanese Society for Familial Tumors
, 日本癌学会
, 日本分子生物学会
, The Molecular Biology Society of Japan
, The Japanese Cancer Association
